Below are the top diagnostic substances stocks on the NASDAQ in terms of cash.
AMAG Pharmaceuticals AMAG had $217.07 million in total cash and no debt for the latest quarter.
IDEXX Laboratories IDXX had $228.36 million in total cash for the latest quarter. However, IDEXX had $262.26 million in total debt for the same period.
Abaxis ABAX had $78.26 million in total cash and $782.00 thousand in total debt for the latest quarter.
Trinity Biotech plc TRIB had $73.10 million in total cash and no debt for the latest quarter.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in